{"id":"human-albumin","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypervolemia and pulmonary edema"},{"rate":"0.1–1%","effect":"Allergic reactions (rash, urticaria, anaphylaxis)"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Chills"},{"rate":null,"effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL1201451","moleculeType":"Protein"},"_dailymed":{"setId":"57bd6811-8619-11e0-9d78-0800200c9a66","title":"KEDBUMIN (ALBUMIN (HUMAN)) INJECTION, SOLUTION [KEDRION S.P.A]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Human albumin is a naturally occurring serum protein that increases plasma colloid osmotic pressure, thereby drawing fluid from the interstitial space into the intravascular compartment to restore circulating blood volume. It also serves as a carrier protein for hormones, fatty acids, bilirubin, and drugs, facilitating their transport and distribution. This makes it useful in treating hypovolemia, shock, and conditions requiring plasma volume restoration or protein supplementation.","oneSentence":"Human albumin acts as a plasma volume expander and carrier protein that restores intravascular oncotic pressure and transports endogenous and exogenous substances throughout the body.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:23:18.622Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypovolemic shock and acute blood loss"},{"name":"Severe hypoproteinemia and malnutrition"},{"name":"Burn management and fluid resuscitation"},{"name":"Liver cirrhosis with ascites"},{"name":"Nephrotic syndrome"}]},"trialDetails":[{"nctId":"NCT03907475","phase":"PHASE2","title":"Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-07-16","conditions":"Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm","enrollment":115},{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT03606967","phase":"PHASE2","title":"Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-04-13","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma","enrollment":70},{"nctId":"NCT06998940","phase":"PHASE3","title":"Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations","status":"RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2026-04-01","conditions":"Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8","enrollment":94},{"nctId":"NCT04310007","phase":"PHASE2","title":"Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-07-13","conditions":"Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8","enrollment":117},{"nctId":"NCT02199145","phase":"NA","title":"Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2015-07-17","conditions":"Membranous Nephropathy","enrollment":52},{"nctId":"NCT04476901","phase":"PHASE2","title":"Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy","status":"RECRUITING","sponsor":"Joshua M Hare","startDate":"2021-05-07","conditions":"Non-ischemic Dilated Cardiomyopathy","enrollment":136},{"nctId":"NCT04143711","phase":"PHASE1, PHASE2","title":"Study of DF1001 in Patients With Advanced Solid Tumors","status":"COMPLETED","sponsor":"Dragonfly Therapeutics","startDate":"2019-11-11","conditions":"Solid Tumor, Adult","enrollment":270},{"nctId":"NCT07183371","phase":"PHASE2","title":"A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Oxford","startDate":"2025-12-15","conditions":"Malaria,Falciparum","enrollment":360},{"nctId":"NCT04895358","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-06-18","conditions":"Breast Neoplasms","enrollment":340},{"nctId":"NCT06489015","phase":"EARLY_PHASE1","title":"Recombinant Human Serum Albumin in the Treatment of AD (Alzheimer Disease) Exploratory Clinical Trials","status":"ACTIVE_NOT_RECRUITING","sponsor":"Protgen Ltd","startDate":"2024-06-28","conditions":"Alzheimer's Disease (AD)","enrollment":30},{"nctId":"NCT05179265","phase":"PHASE1","title":"Recombinant Human Serum Albumin in Healthy Subjects","status":"COMPLETED","sponsor":"Protgen Ltd","startDate":"2021-03-29","conditions":"Hepatic Ascites","enrollment":48},{"nctId":"NCT05249374","phase":"PHASE1","title":"Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects","status":"COMPLETED","sponsor":"Protgen Ltd","startDate":"2021-10-14","conditions":"Hepatic Ascites","enrollment":36},{"nctId":"NCT06553456","phase":"PHASE2, PHASE3","title":"Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites","status":"COMPLETED","sponsor":"Protgen Ltd","startDate":"2024-08-19","conditions":"Cirrhotic Ascites","enrollment":390},{"nctId":"NCT05858853","phase":"PHASE2, PHASE3","title":"Phase II/III of Recombinant Human Serum Albumin","status":"COMPLETED","sponsor":"Protgen Ltd","startDate":"2023-05-24","conditions":"Cirrhotic Ascites","enrollment":92},{"nctId":"NCT05491512","phase":"PHASE2","title":"A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2022-08-04","conditions":"HPV, Throat Cancer, Oropharyngeal Carcinoma","enrollment":121},{"nctId":"NCT06018337","phase":"PHASE3","title":"A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)","status":"ACTIVE_NOT_RECRUITING","sponsor":"DualityBio Inc.","startDate":"2024-01-18","conditions":"Metastatic Breast Cancer","enrollment":541},{"nctId":"NCT07449364","phase":"NA","title":"Allogeneic Human Mesenchymal Stem Cell Infusion for Frailty Patient","status":"COMPLETED","sponsor":"Daewoong Group Indonesia","startDate":"2025-03-24","conditions":"Frailty in Older Adults","enrollment":10},{"nctId":"NCT05325632","phase":"PHASE2","title":"Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2021-10-28","conditions":"HER2-positive Breast Cancer","enrollment":53},{"nctId":"NCT07435922","phase":"","title":"Evaluate Recombinant Human Serum Albumin From Oryza Sativa In Patients With Hypoalbuminemia and/or Hypovolemia Requiring Urgent Treatment","status":"NOT_YET_RECRUITING","sponsor":"Healthgen Biotechnology Corp.","startDate":"2026-02-24","conditions":"Hypoalbuminemia, Hypovolemia","enrollment":2000},{"nctId":"NCT04104672","phase":"PHASE1","title":"A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Arcus Biosciences, Inc.","startDate":"2019-11-06","conditions":"Advanced Pancreatic Cancer","enrollment":196},{"nctId":"NCT05580601","phase":"PHASE1, PHASE2","title":"Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2023-05-05","conditions":"Acute Myeloid Leukemia","enrollment":20},{"nctId":"NCT07408583","phase":"PHASE1, PHASE2","title":"Prenatal Transplantation for Fetuses With Fanconi Anemia","status":"NOT_YET_RECRUITING","sponsor":"Agnieszka Czechowicz","startDate":"2026-07","conditions":"Fanconi Anemia, Anemia, Hypoplastic, Congenital, Congenital Bone Marrow Failure Syndromes","enrollment":12},{"nctId":"NCT04892953","phase":"PHASE2","title":"Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-07-07","conditions":"Stage III Lung Cancer AJCC v8, Stage III Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Cancer AJCC v8","enrollment":51},{"nctId":"NCT07415655","phase":"PHASE2","title":"Modulation of Cerebral Ischemia by Albumin","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Hradec Kralove","startDate":"2026-02-03","conditions":"Ischemic Stroke","enrollment":100},{"nctId":"NCT05722938","phase":"PHASE3","title":"Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)","status":"RECRUITING","sponsor":"Biotest","startDate":"2023-09-09","conditions":"Community-acquired Pneumonia","enrollment":590},{"nctId":"NCT03949855","phase":"PHASE2","title":"Belimumab With Rituximab for Primary Membranous Nephropathy","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2020-03-06","conditions":"Membranous Nephropathy, Nephrotic Syndrome","enrollment":58},{"nctId":"NCT05208242","phase":"PHASE2, PHASE3","title":"Strong Albumin Solutions in Patients With Septic Shock","status":"COMPLETED","sponsor":"Manchester University NHS Foundation Trust","startDate":"2023-11-10","conditions":"Sepsis, Septic Shock, Shock, Toxic","enrollment":47},{"nctId":"NCT05857371","phase":"PHASE2","title":"Safety and Potential Effect of Innovative Treatment by Adjuvant Injection of Stromal Vascular Fraction From Autologous Adipose Tissue of URethral Stenosis With Endoscopic Urethrotomy","status":"RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2024-03-13","conditions":"Urethral Stenosis","enrollment":20},{"nctId":"NCT05352750","phase":"PHASE1","title":"Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sonnet BioTherapeutics","startDate":"2022-04-20","conditions":"Advanced Solid Tumor, Soft Tissue Sarcoma Adult","enrollment":42},{"nctId":"NCT06528093","phase":"PHASE1","title":"A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2024-10-16","conditions":"Pancreatic Ductal Adenocarcinoma","enrollment":8},{"nctId":"NCT05056220","phase":"PHASE3","title":"Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites","status":"RECRUITING","sponsor":"Aleksander Krag","startDate":"2024-02-26","conditions":"Decompensated Cirrhosis and Ascites","enrollment":240},{"nctId":"NCT02922413","phase":"PHASE2","title":"Panhematin for Prevention of Acute Attacks of Porphyria","status":"TERMINATED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2015-10-30","conditions":"Acute Intermittent Porphyria, Hereditary Coproporphyria, Variegate Porphyria","enrollment":13},{"nctId":"NCT07371624","phase":"PHASE1, PHASE2","title":"A Study of the Safety, Tolerability and Preliminary Efficacy of B2065 in Patients With Acute Ischemic Stroke.","status":"RECRUITING","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2025-12-31","conditions":"Acute Ischemic Stroke","enrollment":54},{"nctId":"NCT07263308","phase":"PHASE3","title":"Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2","status":"RECRUITING","sponsor":"Capital Medical University","startDate":"2025-12-18","conditions":"Acute Ischemic Stroke","enrollment":1192},{"nctId":"NCT07365475","phase":"PHASE2","title":"Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Huanhu Hospital","startDate":"2026-01-30","conditions":"Acute Ischemic Stroke From Large Vessel Occlusion","enrollment":306},{"nctId":"NCT07349342","phase":"NA","title":"Stable Versus Unstable Resistance Training Effects on Physical Fitness and Physiological Biomarkers of Untrained Male University Students","status":"ACTIVE_NOT_RECRUITING","sponsor":"Addis Ababa University","startDate":"2025-11-12","conditions":"No Condition, Health Young Males","enrollment":54},{"nctId":"NCT05624996","phase":"PHASE3","title":"Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"NRG Oncology","startDate":"2023-07-12","conditions":"Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8","enrollment":474},{"nctId":"NCT01783288","phase":"NA","title":"Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University","startDate":"2013-02","conditions":"Postural Tachycardia Syndrome","enrollment":110},{"nctId":"NCT03265808","phase":"PHASE1, PHASE2","title":"Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Alcohol Use Disorder and Major Depression.","status":"COMPLETED","sponsor":"Ihsan M Salloum, MD, MPH","startDate":"2018-03-18","conditions":"Major Depressive Disorder, Alcohol Use Disorder","enrollment":31},{"nctId":"NCT03181100","phase":"PHASE2","title":"Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-07-27","conditions":"Metastatic Thyroid Gland Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma, Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v8","enrollment":50},{"nctId":"NCT07320430","phase":"NA","title":"Comparative Study Between Sclerosing Agents Used in Treatment of Vascular Malformation","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-02-14","conditions":"Vascular Malformation","enrollment":75},{"nctId":"NCT07020715","phase":"PHASE2","title":"A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2026-03-01","conditions":"Multiple Sclerosis","enrollment":14},{"nctId":"NCT07299253","phase":"EARLY_PHASE1","title":"Preclinical Safety Evaluation and First-in-Human Translational Study of [177Lu]Lu-TEFAPI-06","status":"COMPLETED","sponsor":"Lanzhou University Second Hospital","startDate":"2023-08-16","conditions":"Metastatic Solid Tumors (Any Localization)","enrollment":5},{"nctId":"NCT07294391","phase":"PHASE2","title":"The Preliminary Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Huanhu Hospital","startDate":"2025-12-10","conditions":"Acute Ischemic Stroke From Large Vessel Occlusion","enrollment":60},{"nctId":"NCT07236736","phase":"NA","title":"Evaluation of SPM™ Topical Cosmetic Application on Skin Appearance, Hydration, and Barrier Support in Healthy Adults","status":"NOT_YET_RECRUITING","sponsor":"Biocoz Global Pte. Ltd.","startDate":"2026-01-30","conditions":"Healthy Skin, Skin Hydration","enrollment":10},{"nctId":"NCT07270874","phase":"PHASE4","title":"Study to Evaluate the Efficacy of Intravenous Administration of Human Albumin Versus Saline Solution in Patients With descompénsate Cirrhosis Grade 1B or Higher Renal Failure","status":"NOT_YET_RECRUITING","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2026-01","conditions":"Decompensated Cirrhosis, AKI - Acute Kidney Injury","enrollment":114},{"nctId":"NCT06492759","phase":"PHASE2","title":"High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-01-31","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma","enrollment":29},{"nctId":"NCT03702920","phase":"PHASE3","title":"Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5%","status":"TERMINATED","sponsor":"Grifols Therapeutics LLC","startDate":"2019-02-21","conditions":"Acute-On-Chronic Liver Failure","enrollment":275},{"nctId":"NCT04390399","phase":"PHASE2","title":"Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"ImmunityBio, Inc.","startDate":"2020-07-21","conditions":"Pancreatic Cancer","enrollment":328},{"nctId":"NCT07071337","phase":"PHASE3","title":"A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy","status":"RECRUITING","sponsor":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.","startDate":"2025-07-18","conditions":"Metastatic Breast Cancer","enrollment":430},{"nctId":"NCT05623111","phase":"PHASE2","title":"Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2023-08-01","conditions":"Diabetic Neuropathy, Painful","enrollment":80},{"nctId":"NCT04044690","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)","status":"TERMINATED","sponsor":"CSL Behring","startDate":"2019-10-21","conditions":"Dermatomyositis","enrollment":134},{"nctId":"NCT06535945","phase":"PHASE4","title":"Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation","status":"RECRUITING","sponsor":"Rennes University Hospital","startDate":"2025-03-26","conditions":"Liver Transplantation, Acute Kidney Injury","enrollment":400},{"nctId":"NCT03818854","phase":"PHASE2","title":"Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome","status":"COMPLETED","sponsor":"Michael A. Matthay","startDate":"2019-11-26","conditions":"Respiratory Distress Syndrome, Adult","enrollment":120},{"nctId":"NCT07150767","phase":"PHASE1","title":"A Clinical Study to Explore the Safety, Tolerability, and Efficacy of Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) Combined With Neoadjuvant Treatment for Locally Advanced Breast Cancer","status":"WITHDRAWN","sponsor":"Beijing Bio-Targeting Therapeutics Technology Co., Ltd","startDate":"2025-03-26","conditions":"Locally Advanced Breast Cancer (LABC)","enrollment":""},{"nctId":"NCT04057833","phase":"PHASE1","title":"E-CEL UVEC Cells as an Adjunct Cell Therapy for the Arthroscopic Rotator Cuff Repair in Adults","status":"ENROLLING_BY_INVITATION","sponsor":"Hospital for Special Surgery, New York","startDate":"2019-11-20","conditions":"Rotator Cuff Tears, Muscle Atrophy or Weakness, Tendon Rupture - Shoulder","enrollment":20},{"nctId":"NCT04701034","phase":"PHASE2","title":"Intravenous Immunoglobulin and Prednisolone for RPL After ART.","status":"COMPLETED","sponsor":"Aalborg University Hospital","startDate":"2021-01-28","conditions":"Habitual Abortion, Recurrent Pregnancy Loss, Fertility Disorders","enrollment":80},{"nctId":"NCT07212582","phase":"PHASE3","title":"Human Albumin for Resuscitation in Surgical Septic Shock: A Randomized Controlled Trial (ALBUS Study)","status":"NOT_YET_RECRUITING","sponsor":"Mahidol University","startDate":"2025-12-01","conditions":"Critical Illness, Septic Shock","enrollment":304},{"nctId":"NCT05630183","phase":"PHASE2","title":"A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Agenus Inc.","startDate":"2023-03-27","conditions":"Metastatic Pancreatic Ductal Adenocarcinoma","enrollment":81},{"nctId":"NCT02725060","phase":"NA","title":"Autoimmune Basis for Postural Tachycardia Syndrome","status":"ENROLLING_BY_INVITATION","sponsor":"Vanderbilt University Medical Center","startDate":"2016-02","conditions":"Postural Orthostatic Tachycardia Syndrome, Postural Tachycardia Syndrome, Tachycardia","enrollment":58},{"nctId":"NCT06675136","phase":"PHASE1","title":"Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2025-10-29","conditions":"Clinical Stage IVB Gastric Cancer AJCC v8, Metastatic Gastric Adenocarcinoma, Metastatic Malignant Neoplasm in the Peritoneum","enrollment":30},{"nctId":"NCT02346747","phase":"PHASE2","title":"A Trial of Vigil for Participants With Ovarian Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gradalis, Inc.","startDate":"2015-02","conditions":"Ovarian Cancer, Ovarian Neoplasms","enrollment":92},{"nctId":"NCT03520686","phase":"PHASE3","title":"Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"ImmunityBio, Inc.","startDate":"2018-05-18","conditions":"Non Small Cell Lung Cancer","enrollment":1538},{"nctId":"NCT04940286","phase":"PHASE2","title":"Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-09-28","conditions":"Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8","enrollment":13},{"nctId":"NCT00608725","phase":"NA","title":"Pathophysiology of Orthostatic Intolerance","status":"ACTIVE_NOT_RECRUITING","sponsor":"Satish R. Raj","startDate":"1996-12","conditions":"Tachycardia, Postural Orthostatic Tachycardia Syndrome","enrollment":260},{"nctId":"NCT03734029","phase":"PHASE3","title":"Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daiichi Sankyo","startDate":"2018-12-27","conditions":"Breast Cancer","enrollment":557},{"nctId":"NCT05840211","phase":"PHASE3","title":"Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2023-05-08","conditions":"Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer","enrollment":654},{"nctId":"NCT05867602","phase":"PHASE2","title":"High Dose Albumin in Refractory Ascites","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2019-03-25","conditions":"Ascites","enrollment":100},{"nctId":"NCT03461900","phase":"NA","title":"Guided Fluid-balance Optimization With Mini-fluid chALlenge During Septic Shock","status":"COMPLETED","sponsor":"University Hospital, Brest","startDate":"2019-06-04","conditions":"Septic Shock","enrollment":535},{"nctId":"NCT04216784","phase":"PHASE4","title":"Compare the Diuretic Effect With Furosemide vs Furosemide and Albumin Combined in Cirrhotic Patients","status":"TERMINATED","sponsor":"Rush University Medical Center","startDate":"2019-12-19","conditions":"Cirrhosis, Liver, Volume Overload, Fluid Overload","enrollment":21},{"nctId":"NCT03211793","phase":"PHASE1, PHASE2","title":"Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2021-10-06","conditions":"Systemic Sclerosis, Digital Ulcer","enrollment":20},{"nctId":"NCT05854641","phase":"PHASE4","title":"Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease","status":"RECRUITING","sponsor":"Cell Biopeutics Resources Sdn Bhd","startDate":"2024-01-01","conditions":"Critical Limb Ischemia, Peripheral Arterial Disease","enrollment":10},{"nctId":"NCT05854615","phase":"PHASE4","title":"Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease","status":"RECRUITING","sponsor":"Cell Biopeutics Resources Sdn Bhd","startDate":"2024-01-01","conditions":"Critical Limb Ischemia, Buerger's Disease","enrollment":3},{"nctId":"NCT04869397","phase":"PHASE2","title":"Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells","status":"TERMINATED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2021-06-14","conditions":"Covid19","enrollment":19},{"nctId":"NCT06934473","phase":"NA","title":"Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals","status":"RECRUITING","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2025-05-21","conditions":"Bloodpressure","enrollment":16},{"nctId":"NCT02219165","phase":"PHASE2","title":"Efficacy of IntraVenous ImmunoGlobulins in Toxic Shock Syndromes: a Paediatric Pilot Study","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2015-01-08","conditions":"Toxic Shock Syndrome","enrollment":30},{"nctId":"NCT06483737","phase":"NA","title":"Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2025-06-24","conditions":"Overt Hepatic Encephalopathy","enrollment":174},{"nctId":"NCT06715605","phase":"PHASE2","title":"A Clinical Trial Evaluating the Safety and Efficacy of Myelin-peptide Loaded tolDC as Treatment for MS","status":"WITHDRAWN","sponsor":"University Hospital, Antwerp","startDate":"2025-04-30","conditions":"Multiple Sclerosis","enrollment":""},{"nctId":"NCT00936819","phase":"PHASE2","title":"The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2013-07-19","conditions":"Anterior Wall Myocardial Infarction","enrollment":47},{"nctId":"NCT07119463","phase":"PHASE2","title":"Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery","status":"RECRUITING","sponsor":"The First Hospital of Jilin University","startDate":"2024-10-29","conditions":"Postoperative Hypoalbuminemia, Postoperative Complications, Gastric Cancer","enrollment":112},{"nctId":"NCT06524739","phase":"PHASE3","title":"Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS","status":"TERMINATED","sponsor":"CSL Behring","startDate":"2024-08-28","conditions":"Post-COVID Postural Orthostatic Tachycardia Syndrome","enrollment":16},{"nctId":"NCT04865107","phase":"PHASE2","title":"Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2021-04-27","conditions":"Covid19, Acute Respiratory Distress Syndrome","enrollment":22},{"nctId":"NCT06299163","phase":"PHASE1","title":"NM32-2668 in Adult Patients With Selected Advanced Solid Tumors","status":"TERMINATED","sponsor":"Numab Therapeutics AG","startDate":"2024-05-01","conditions":"Ovarian Carcinoma, Fallopian Tube Carcinoma, Peritoneal Carcinoma","enrollment":11},{"nctId":"NCT05239182","phase":"PHASE2","title":"9-ING-41 Plus Retifanlimab and Gemcitabine/Nab-Paclitaxel in Patients With Advanced Pancreatic Adenocarcinoma","status":"TERMINATED","sponsor":"Anwaar Saeed","startDate":"2022-01-26","conditions":"Pancreatic Adenocarcinoma","enrollment":7},{"nctId":"NCT04879368","phase":"PHASE3","title":"RegoNivo vs Standard of Care Chemotherapy in AGOC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Australasian Gastro-Intestinal Trials Group","startDate":"2021-06-01","conditions":"Gastro-Oesophageal Cancer","enrollment":450},{"nctId":"NCT00199862","phase":"NA","title":"Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2004-02","conditions":"Colorectal Neoplasms, Colorectal Cancer, Colorectal Tumor","enrollment":30},{"nctId":"NCT05148286","phase":"PHASE4","title":"Albumin and Crystalloid Administration in Septic Shock","status":"RECRUITING","sponsor":"Asan Medical Center","startDate":"2022-01-17","conditions":"Septic Shock","enrollment":2426},{"nctId":"NCT06500208","phase":"PHASE2","title":"Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BC","status":"RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2024-11-01","conditions":"Breast Cancer","enrollment":48},{"nctId":"NCT05451043","phase":"PHASE2","title":"Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)","status":"RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2023-07-05","conditions":"Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer","enrollment":62},{"nctId":"NCT06394661","phase":"PHASE2","title":"Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Henan Cancer Hospital","startDate":"2024-04-28","conditions":"Breast Cancer","enrollment":109},{"nctId":"NCT06781281","phase":"","title":"NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.","status":"RECRUITING","sponsor":"Henan Cancer Hospital","startDate":"2024-12-04","conditions":"Breast Cancer Invasive","enrollment":709},{"nctId":"NCT00868530","phase":"PHASE3","title":"Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-09","conditions":"Hemophilia A","enrollment":53},{"nctId":"NCT05531149","phase":"PHASE3","title":"Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia","status":"TERMINATED","sponsor":"Biotest","startDate":"2022-12-22","conditions":"Respiratory Infection, Pneumonia, Community-acquired Pneumonia","enrollment":107},{"nctId":"NCT03451292","phase":"PHASE3","title":"Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and Ascites","status":"COMPLETED","sponsor":"Grifols Therapeutics LLC","startDate":"2018-07-24","conditions":"Decompensated Cirrhosis and Ascites","enrollment":410},{"nctId":"NCT05937048","phase":"NA","title":"Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D).","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2023-07-30","conditions":"Decompensated Cirrhosis","enrollment":120},{"nctId":"NCT04442126","phase":"PHASE1, PHASE2","title":"A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors","status":"TERMINATED","sponsor":"Numab Therapeutics AG","startDate":"2020-08-19","conditions":"Advanced Solid Tumor, Non-small Cell Lung Cancer, Colorectal Cancer","enrollment":52},{"nctId":"NCT05775211","phase":"NA","title":"Effects of Intrauterine Administration of Autologous PBMC Modulated With IFNt on Endometrial Cell Populations","status":"RECRUITING","sponsor":"Nadezhda Women's Health Hospital","startDate":"2023-03-13","conditions":"Infertility","enrollment":300},{"nctId":"NCT05775198","phase":"NA","title":"Effect of Intrauterine Administration of Autologous PBMC Modulated With IFNt on IVF Outcome","status":"RECRUITING","sponsor":"Nadezhda Women's Health Hospital","startDate":"2023-03-01","conditions":"Infertility, Female, IVF","enrollment":300},{"nctId":"NCT06654687","phase":"NA","title":"Transthoracic Echocardiographic Monitoring of Cardiac Output Effects of Colloid Preload and Crystalloid Coload During Cesarean Delivery Under Spinal Anesthesia","status":"COMPLETED","sponsor":"Sameh Fathy","startDate":"2024-10-27","conditions":"Pregnancy, Cesarean Delivery, Spinal Anesthesia Induced Hypotension","enrollment":162}],"_emaApprovals":[],"_faersSignals":[{"count":52,"reaction":"INFUSION RELATED REACTION"},{"count":49,"reaction":"ANAEMIA"},{"count":49,"reaction":"DIARRHOEA"},{"count":43,"reaction":"DYSPNOEA"},{"count":39,"reaction":"PYREXIA"},{"count":38,"reaction":"CHILLS"},{"count":33,"reaction":"LYMPHOCYTE COUNT DECREASED"},{"count":33,"reaction":"PNEUMONIA"},{"count":30,"reaction":"DRUG INEFFECTIVE"},{"count":28,"reaction":"HAEMOGLOBIN DECREASED"}],"_approvalHistory":[],"publicationCount":3510,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Albumin infusion","Human-Albumin 20 % Behring, salzarm","albumin","Albumin","Human Albumin 5% CSL Behring"],"phase":"marketed","status":"active","brandName":"Human albumin","genericName":"Human albumin","companyName":"Hamad Medical Corporation","companyId":"hamad-medical-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Human albumin is the most abundant protein in human blood plasma, making up about half of serum protein, and is produced in the liver. It is a protein-based sequestering agent that binds to bilirubin, a function that is utilized in various clinical trials for conditions such as Acute Respiratory Distress Syndrome and COVID-19 Pneumonia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":15,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}